Volcano: Q4 results to be Wall Street estimates; C.R. Bard unit recalls XenMatrix product;

> Medical devicemaker Volcano says it expects fourth-quarter revenue of $81 million, easily exceeding estimates on Wall Street. News

> C.R. Bard disclosed Tuesday that its Davol subsidiary has voluntarily recalled a surgical-graft product called XenMatrix that is used in hernia and abdominal wall repair. Story

> TriReme Medical has announced that it has signed an exclusive distribution and sales agreement for TriReme's complete line of advanced peripheral and coronary balloon dilatation catheters with Century Medical, a leading independent device distributor for the important Japanese market. TriReme release

> As more hospitals and clinics plug patient monitoring equipment and other devices into traditional data networks, the closer the FDA comes to regulating the networks as medical devices. Currently, most hospitals and clinics manage medical devices on discrete networks to better ensure the safety and security of those systems. But there is a trend toward consolidation, particularly onto wireless networks, for easier management. Report

> Sydney-based medical device manufacturer Medical Australia snared a third original equipment manufacturer agreement, the latest with global healthcare company Pharmatel Fresenius Kabi AG of Germany, with immediate revenue generation. Item

> IntraPace has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe. IntraPace release

> Medtronic Chief Executive William Hawkins, who is expected to step aside in April, said Monday that he feels confident that he's leaving the medical device maker on solid footing. Article

> Medical devicemaker Boston Scientific Corp. said Monday it settled a patent dispute over stents with Israel-based Medinol Ltd. and will record a gain in the fourth quarter. Story

> Neomend has received the European Union CE Mark for the company's ProGEL PLATINUM Surgical Sealant. Neomend release

And Finally... GE Healthcare and the Fiesta Bowl collaborated to implement innovative, medical imaging technologies on site during the Tostitos BCS National Championship game. GE Healthcare release

Suggested Articles

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.

Since launching Grail into the world in 2016, Illumina has watched the cancer blood test developer grow into a multibillion-dollar startup enterprise.